Novel Vaccine Delivery System Market worth USD 9306.1 million by 2027

1. Market Research Report EXCLUSIVE EDITION Global Novel Vaccine Delivery System Market Research Global Industry Analysis, Forecast and Trends, 2021-2027 Report © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

2. Global Novel Vaccine Delivery System Market © 2020 Statsville Consulting Private Limited Market Statsville Group (MSG) A part of Statsville Consulting Private Limited American Office American Office – 416, East Standsberry Street, Perkins, Oklahoma 74059, USA EMEA EMEA– 1165 Budapest 16 Diósy Lajos u. 24., Europe Asia Asia- -Pacific Office Pacific Office – F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 www.marketstatsville.com Disclaimer Disclaimer: : Any information and/or material provided by Statsville Consulting Private Limited, including any and all the analysis and/or research from Market Statsville Group (MSG), is offered to a selected group of customers in response to orders for such information, material, analysis, and/or research. As a customer of Statsville Consulting, you acknowledge that our information, material, and/or services are for your internal use only, and not for any external use and/or dissemination, or general publication, and/or disclosure to any third parties. Any and all the information and/or material provided by Statsville Consulting are based on primary interviews and/or secondary research, and are, therefore, subject to fluctuation and variance. Statsville Consulting takes no responsibility for any incorrect information and/or material supplied to us by sources we rely on, and no part of our analysis or research may be given, lent, resold, or disclosed to any third parties, including non-customers, without explicit or written permission from Statsville Consulting. Unauthorized reproduction and/or transmission of our information, material, analysis, and/or research in any form and by any means, including photocopying, mechanical/electronic recording,or otherwise, without the explicit and written permission of Statsville Consulting, is expressly and clearly prohibited. Any use of the information, material, analysis, and/or research provided by Statsville Consulting is at your sole risk; you acknowledge that the information, material, analysis, and/or research is provided “as is” and that Statsville Consulting provides no warranty of any kind, express or implied, with regard to the information, material, analysis, and/or research, including but not limited to, merchantability and fitness for any purpose and/or use. At the end, Statsville Consulting will be responsiblefor the final decision of any action. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

3. ABOUT MARKET STATSVILLE GROUP (MSG) Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG was initiated its working in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services. Market Statsville is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. Market Statsville is your global data intelligence partner for reliable market research data, data gathering, and analytical services. MSG also has an extensive network of top-flight domestic and global research personals around the world, enabling us to provide high-quality worldwide research solutions that cater to a well-established company, government organizations, or a startup. MSG's clients have the authority to work directly with one or more of our researchers to gather the most useful data knowledge and analytical plan to formulate it in the actual practice. Market Statsville Group believes that to succeed, companies or individuals must blend digital and human capabilities most efficiently. MSG diverse and experienced global team of business consultants and market researchers will ensure the valuable reports for our clients through digging in-depth market information and functional expertise to continuously spark the changes and real-time valuation of variation in the market/industry. MSG works in a uniquely collaborative model throughout the business process across the globe to assist the client's company with the most accurate information that they are aiming for in the reports. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

4. RESEARCH PROCESS Our research is an optimum culmination of secondary and primary research, with the latter playing a major role. We also have an in-house repository and access to a number of external regional and global paid databases to help address specific requirements of our clients. The research process begins with a holistic secondary research, followed by expert interviews. The information gathered is then comprehensively analyzed by our highly experienced in-house research panel © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

5. Novel Vaccine Delivery System Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027 Novel Vaccine Delivery System Market by Delivery Mode (Intradermal, Subcutaneous, Intramuscular, and Other), by Device (Syringe, Needle-free injection System, and Others), by Region – Global Share and Forecast to 2027 Description The Market Statsville Group (MSG) publishes the new report on the "Novel Vaccine Delivery System Market by Delivery Mode (Intradermal, Subcutaneous, Intramuscular, and Other), by Device (Syringe, Needle- free injection System, and Others), by Region – Global Share and Forecast to 2027". The global novel vaccine delivery system market size is expected to grow from USD 5,029.6 million in 2020 to USD 9306.1 million by 2027, at a CAGR of 10.8% during the forecast period. The development of novel vaccines using various approaches includes structure-based immunogen design, gene-based vaccine platforms, and recombinant antigens with potent adjuvants, which are expected to drive market growth during the forecast period significantly. These technologies are producing encouraging results in the development of vaccines for globally important diseases such as tuberculosis, influenza and respiratory syncytial virus, and novel coronavirus, which boost the growth of novel vaccine delivery systems market during the forecast period. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

6. In addition, mRNA vaccines are a new type of vaccine to protect against infectious diseases such as COVID-19. It consists of synthetic mRNA strands encoding the SARS-CoV-2 Spike glycoprotein, packaged in lipid nanoparticles to deliver mRNA to cells. Browse complete report: https://www.marketstatsville.com/novel-vaccine-delivery-system-market Global Novel Vaccine Delivery System Market Segmentation The overall novel vaccine delivery system market has been segmented into the delivery mode, device, and region. •By Delivery Mode (Intradermal, Subcutaneous, Intramuscular, and Other) •By Device (Syringe, Needle-free injection System, and Others) •By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru) Syringe, by device, is estimated to hold the largest market share during the forecast period On the basis of device, the novel vaccine delivery systems market is categorized into the syringe, needle-free injection system, and others. In 2020, the syringe had the largest market revenue, with 55.3% of the market share. The syringe is a cylindrical medical device with a thin hollow needle attached to a tube and a plunger © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

7. Syringes extract fluids from the body or inject fluids into the body. Two types of syringes are available based on usage: disposable syringes and reusable syringes. Disposable syringes are widely used to inject drugs, vaccines or draw a blood sample from the body. In addition, disposable syringes are intended for single-use, which prevents sterilization. You Can Purchase Complete Report@ https://www.marketstatsville.com/buy-now/novel-vaccine-delivery- system-market The growth of the global syringe market is driven by a rise in the incidence of chronic diseases and a surge in demand for vaccination & immunization. Additionally, rapid growth in the geriatric population and demand for injectable drugs accelerate the market growth. The Occupational Safety and Health Administration estimates that approximately 5.6 million healthcare professionals were susceptible to blood-borne diseases in 2014, owing to the rise in prevalence of needlestick and other sharps object injuries. Don't miss out on business opportunities in Novel Vaccine Delivery System Market. Speak to our research analyst and gain crucial market insights to grow your business. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

8. North America accounts for the largest market share in novel vaccine delivery system market 2020 Based on the regions, the global novel vaccine delivery system market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2020, North America accounted for the highest market share of 36.8% in the global novel vaccine delivery system market and was anticipated to maintain its dominance throughout the forecast period. The three major countries of North America considered in the report include the U.S., Canada, and Mexico. The U.S. was the largest revenue contributor in North America in 2020 and is a mature market. The rising incidence of several chronic illnesses and disorders, such as polio, measles, and influenza, is driving demand for vaccination and contributes toward the growth of the novel vaccine delivery system in this region. The Centers for Disease Control and Prevention (CDC) stated that between October 1, 2019, and April 4, 2020, about 39,000,000 to 56,000,000 flu infections were reported in the U.S., with 24,000 to 62,000 flu fatalities. In addition, well-established healthcare infrastructure higher buying power, higher healthcare expenditure levels, and stringency of regulations are some factors that drive the growth of the novel vaccine delivery system market in this region. Furthermore, every year the Centers for Disease Control and Prevention (CDC) publishes a revised schedule for vaccinations recommended to prevent several diseases in America, which is expected to create beneficial opportunities for a novel vaccine delivery system market. Likewise, the number of COVID-19 infections is estimated to positively impact the growth of the novel vaccine delivery system market in the U.S, as several companies have promising vaccine candidates currently in their clinical trial phases 2 and 3. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

9. Access full TOC, Table of Figure, Chart, etc https://www.marketstatsville.com/table-of-content/novel-vaccine- delivery-system-market This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the novel vaccine delivery system market. It also consists of the profiles of leading companies such as Inovio Pharmaceuticals, Inc. (Bioject Medical Technologies), Becton Dickinson & Company, Altaris Capital Partners, LLC (Kindeva Drug Delivery), Gurnet Point Capital (Corium International Inc.), Gerresheimer AG, PharmaJet, Inc., Carl Zeiss Foundation (Schott AG), Retractable Technologies, Inc, VAXXAS Pty Ltd., and Terumo Corporation. These market players have focused on acquisitions and expansion to gain a larger market share in the novel vaccine delivery system market. Access For Report Description, https://www.marketstatsville.com/press-release/novel-vaccine-delivery-system- market © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

10. Thank You Thank You Market Market Statsville StatsvilleGroup (MSG) Group (MSG) F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 Phone : +91 702 496 8807 Mail : sales@marketstatsville.com 416, East Standsberry Street, Perkins, Oklahoma 74059, US Phone : +1 580 250 2707 Mail : sales@marketstatsville.com